- Home
- TSHA vs RBB Comparison
TSHA vs RBB Comparison
Compare TSHA & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- RBB
- Stock Information
- Founded
- TSHA 2019
- RBB 2008
- Country
- TSHA United States
- RBB United States
- Employees
- TSHA N/A
- RBB N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- RBB Major Banks
- Sector
- TSHA Health Care
- RBB Finance
- Exchange
- TSHA Nasdaq
- RBB Nasdaq
- Market Cap
- TSHA 334.1M
- RBB 374.0M
- IPO Year
- TSHA 2020
- RBB 2017
- Fundamental
- Price
- TSHA $1.61
- RBB $17.25
- Analyst Decision
- TSHA Strong Buy
- RBB Hold
- Analyst Count
- TSHA 8
- RBB 4
- Target Price
- TSHA $6.63
- RBB $21.25
- AVG Volume (30 Days)
- TSHA 2.1M
- RBB 53.1K
- Earning Date
- TSHA 02-26-2025
- RBB 02-03-2025
- Dividend Yield
- TSHA N/A
- RBB 3.71%
- EPS Growth
- TSHA N/A
- RBB N/A
- EPS
- TSHA N/A
- RBB 1.47
- Revenue
- TSHA $9,915,000.00
- RBB $104,842,000.00
- Revenue This Year
- TSHA N/A
- RBB N/A
- Revenue Next Year
- TSHA N/A
- RBB $7.66
- P/E Ratio
- TSHA N/A
- RBB $11.73
- Revenue Growth
- TSHA N/A
- RBB N/A
- 52 Week Low
- TSHA $1.19
- RBB $16.54
- 52 Week High
- TSHA $4.32
- RBB $25.30
- Technical
- Relative Strength Index (RSI)
- TSHA 46.14
- RBB 24.86
- Support Level
- TSHA $1.46
- RBB $17.41
- Resistance Level
- TSHA $1.76
- RBB $18.48
- Average True Range (ATR)
- TSHA 0.15
- RBB 0.77
- MACD
- TSHA 0.01
- RBB -0.03
- Stochastic Oscillator
- TSHA 39.33
- RBB 2.35
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.